Others
others
Research Areas
- Actin(12)
- Inhibitory Antibodies(174)
- Adenylate cyclase(29)
- AhR(13)
- Aldose reductase(26)
- Arginase(13)
- AT Receptors(1)
- Autotaxin(4)
- ATP citrate lyase (10)
- BCRP(15)
- ROR/RAR/RXR(92)
- Caged Compounds(3)
- Calmodulin protein kinase II(1)
- CaM kinase II(9)
- Carbonic Anhydrase(28)
- Cell Penetrating Peptide(2)
- Ceramidases(4)
- CERK(1)
- Collagen proline hydroxylase(1)
- COT/TpI2
- COMT(11)
- CPA
- CPG2
- Cytokine(4)
- dCTP Pyrophosphatase(1)
- DHODH(1)
- Diacylglycerol Kinase(1)
- DNA Stain(17)
- eIF2a(2)
- Endopeptidase(3)
- Enzyme Substrates / Activators(69)
- ES-FLI1/RHA(2)
- Farnesyl Diphosphate Synthase(1)
- FBPase(4)
- FLAP(10)
- Fluorescent Probes(305)
- GLI(4)
- Glycoprotein(5)
- Glycosylase(5)
- Saccharides and Glycosides(17)
- Glyoxalase I(1)
- GSNOR(2)
- GSTP1-1
- Guanylate Cyclase (29)
- Guanylyl Cyclase(7)
- Gutathione S-transferase(12)
- Heme oxygenase(10)
- Hexokinase(6)
- Hydroxylases(10)
- IL Receptor(1)
- Imidazoline Receptors(18)
- IMPDH(1)
- Inositol Phosphatases(4)
- Lp-PLA2(1)
- LpxC(1)
- Matrix Metalloprotease(1)
- MDR multidrug resistance(44)
- Menin-MLL(5)
- MGMT(1)
- Mineralocorticoid Receptor(23)
- Miscellaneous Compounds(9)
- MyD88(9)
- Myosin(25)
- NAE(2)
- NADPH Oxidase(16)
- Nampt(27)
- Natriuretic Peptide Receptors(4)
- Nitric Oxide(74)
- Nuclear Receptors(13)
- Oxygenases/Oxidases(5)
- PDHK(10)
- PGC-1α(5)
- Pregnane X Receptors(2)
- Reductases(6)
- Renin(12)
- Retinoid X Receptors(11)
- Squalene epoxidase(4)
- SGK(11)
- sFRP-1(3)
- SPHK(18)
- Synthases/Synthetases(12)
- Tachykinin(6)
- Thrombopoietin Receptor(7)
- Thymidine phosphorylase(4)
- Transcription Factors(118)
- Transketolase(3)
- β(1,3)-D-Glucan Synthase(2)
- β-Lactamase(3)
- XAO(4)
- Others(1570)
- BMI-1(1)
- Hydrogen Peroxide
- Ascorbic Acid
- SOD(8)
- Homodimerizers(2)
- Renal Diseases(9)
- PAF-AH
- FAS(24)
- calmodulin(3)
- Protein synthesis(4)
- Epac(1)
- MAGL(19)
- exocytosis(1)
- peroxiredoxins(1)
- Glucosidase(47)
- Estrogen Receptor/ERR(175)
- Progesterone Receptor(37)
- Cyclase(6)
- Environmental Toxicology(241)
- Glycerolipid Lipases(15)
- Lipases(26)
- Multidrug-Resistance Proteins(8)
- Negative Controls(9)
- Nucleic Acid Turnover/Signaling(56)
- Organ- & System-Specific Toxicity(157)
- Pesticides(102)
- Pharmaceutical Impurities(35)
- Sulfotransferases(4)
- Tec(3)
- Toxicology(161)
- Xenobiotic Sensing(23)
- UDP Glucuronosyltransferases(46)
- Amino Acid Derivatives(43)
- Drug Intermediate(244)
- Drug Isomer(57)
- Insecticide(14)
- MOFs(329)
- Phytohormone(7)
- SHMT(4)
- Phosphoramidites(24)
Products Related to Others(4260)
- GC73348A2-Iso5-2DC18CAS: 2412492-07-8Purity: >98.00%
A2-Iso5-2DC18 is a didroimidazole-linked lipid, served as potent mRNA delivery vehicle.
- GC73376FOXM1-IN-1CAS: 2864407-22-5Purity: >99.00%
FOXM1-IN-1 is a potent FOXM1 inhibitor with an IC50 value of 2.65 µM.
- GC73378Anticancer agent 93CAS: 94205-22-8Purity: >98.00%
Anticancer agent 93 is a 4-droxycoumarin derivative.
- GC73402(16R)-Epothilone DPurity: >95.00%
(16R)-Epothilone D is the isomer of Epothilone D , and can be used as an experimental control.
- GC73404Adrixetinib TFAPurity: >99.00%
Adrixetinib (TFA) is an inhibitor of protein tyrosine kinase with antineoplastic activity.
- GC73440TNG-0746132CAS: 2821749-57-7Purity: >99.00%
TNG-0746132 can be used for synthesis of the compound with anticancer activity.
- GC73453Hi 76-0079CAS: 374567-94-9Purity: >99.00%
Hi 76-0079 (Compound 31) is a hormone-sensitive lipase (HSL) inhibitor with an IC50 of 184 nM.
- GC73461SOS1 agonist-1CAS: 2245237-61-8Purity: >97.00%
SOS1 agonist-1 (compound 79) is an agonist for the Son of sevenless homologue SOS1.
- GC73463Ac-PLVE-FMKCAS: 2679825-26-2Purity: >98.00%
Ac-PLVE-FMK (Ac-Pro-Leu-Val-Glu(OMe)-CH2F), a tetrapeptidyl m-FMKs, is a Cats inhibitor.
- GC73479NSC 194308CAS: 90379-42-3Purity: >98.00%
NSC 194308, a U2AF2-RNA complexes enhancer, increases association of the U2AF1-U2AF2-SF1-splice site RNA complex by binding a site between the U2AF2 RNA recognition motifs (RRM1 and RRM2).
- GC73492Sperm motility agonist-2CAS: 926079-67-6Purity: >98.00%
Sperm motility agonist-2 (compound 797) is a Sperm motility agonist.
- GC73502Deruxtecan 2-hydroxypropanamideCAS: 2577204-16-9Purity: >98.00%
Deruxtecan 2-droxypropanamide is a highly stable Deruxtecan analog that specifically binds to receptors highly expressed in tumor cells.
- GC73529FAP Ligand 1CAS: 2230625-76-8Purity: >97.00%
FAP Ligand 1 (FL), a high-affinity FAP small-molecule ligand, is used to target attached drugs to FAP-expressing fibroblasts and can be used in radiation imaging studies of targeted cancers.
- GC73530PAT1inh-B01 hydrochloridePurity: >98.00%
PAT1inh-B01 drocholide is a selective SLC26A6 inhibitor.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC73344 | TDO-IN-1 | 2490672-92-7 | >99.00% | |
TDO-IN-1 is an orally active and selective inhibitor of tryptophan 2,3-dioxygenase (TDO), shows excellent selectivity over indoleamine-2,3-dioxygenase (IDO), with an IC50 value of 0.62 μM (IDO). | ||||
| GC73348 | A2-Iso5-2DC18 | 2412492-07-8 | >98.00% | |
A2-Iso5-2DC18 is a didroimidazole-linked lipid, served as potent mRNA delivery vehicle. | ||||
| GC73366 | NNMT-IN-4 | 2947393-64-6 | >99.00% | |
NNMT-IN-4 (compound 38) is a selective, uncompetitive and membrane permeability nicotinamide N-metltransferase (NNMT) inhibitor with IC50 of 42 and 38 nM in vitro biochemical and cell-based assays, respectively. | ||||
| GC73376 | FOXM1-IN-1 | 2864407-22-5 | >99.00% | |
FOXM1-IN-1 is a potent FOXM1 inhibitor with an IC50 value of 2.65 µM. | ||||
| GC73378 | Anticancer agent 93 | 94205-22-8 | >98.00% | |
Anticancer agent 93 is a 4-droxycoumarin derivative. | ||||
| GC73393 | JS6 | 950244-33-4 | >99.00% | |
JS6 is a Bcl3 inhibitor, and inhibits Bcl3-NF-kB1 binding. | ||||
| GC73402 | (16R)-Epothilone D | - | >95.00% | |
(16R)-Epothilone D is the isomer of Epothilone D , and can be used as an experimental control. | ||||
| GC73404 | Adrixetinib TFA | - | >99.00% | |
Adrixetinib (TFA) is an inhibitor of protein tyrosine kinase with antineoplastic activity. | ||||
| GC73440 | TNG-0746132 | 2821749-57-7 | >99.00% | |
TNG-0746132 can be used for synthesis of the compound with anticancer activity. | ||||
| GC73453 | Hi 76-0079 | 374567-94-9 | >99.00% | |
Hi 76-0079 (Compound 31) is a hormone-sensitive lipase (HSL) inhibitor with an IC50 of 184 nM. | ||||
| GC73455 | 9-Amino-NeuAc | 153232-60-1 | >98.00% | |
9-Amino-NeuAc is a substrate of synthase. | ||||
| GC73461 | SOS1 agonist-1 | 2245237-61-8 | >97.00% | |
SOS1 agonist-1 (compound 79) is an agonist for the Son of sevenless homologue SOS1. | ||||
| GC73463 | Ac-PLVE-FMK | 2679825-26-2 | >98.00% | |
Ac-PLVE-FMK (Ac-Pro-Leu-Val-Glu(OMe)-CH2F), a tetrapeptidyl m-FMKs, is a Cats inhibitor. | ||||
| GC73468 | JS11 | 1394592-04-1 | >99.00% | |
JS11 is an inhibitor for natriuretic polypeptide receptor 1 (Npr1) with an IC50 of 1.9 μM for hNpr1. | ||||
| GC73479 | NSC 194308 | 90379-42-3 | >98.00% | |
NSC 194308, a U2AF2-RNA complexes enhancer, increases association of the U2AF1-U2AF2-SF1-splice site RNA complex by binding a site between the U2AF2 RNA recognition motifs (RRM1 and RRM2). | ||||
| GC73492 | Sperm motility agonist-2 | 926079-67-6 | >98.00% | |
Sperm motility agonist-2 (compound 797) is a Sperm motility agonist. | ||||
| GC73495 | PDS-0330 | 2904682-19-3 | >99.00% | |
PDS-0330 is a specific and potent Claudin-1 inhibitor. | ||||
| GC73502 | Deruxtecan 2-hydroxypropanamide | 2577204-16-9 | >98.00% | |
Deruxtecan 2-droxypropanamide is a highly stable Deruxtecan analog that specifically binds to receptors highly expressed in tumor cells. | ||||
| GC73507 | AGPS-IN-1 | 2316782-88-2 | >99.00% | |
AGPS-IN-1 (Compound 2i) is an effective AGPS binder. | ||||
| GC73508 | TCRS-417 | 2032123-28-5 | >95.00% | |
TCRS-417 (T417) is a small molecule compound capable of docking to the interface between PBX1 and its cognate DNA target sequence, effectively interfering with PBX1-DNA interaction. | ||||
| GC73529 | FAP Ligand 1 | 2230625-76-8 | >97.00% | |
FAP Ligand 1 (FL), a high-affinity FAP small-molecule ligand, is used to target attached drugs to FAP-expressing fibroblasts and can be used in radiation imaging studies of targeted cancers. | ||||
| GC73530 | PAT1inh-B01 hydrochloride | - | >98.00% | |
PAT1inh-B01 drocholide is a selective SLC26A6 inhibitor. | ||||
| GC73534 | (9R,12aR)-AZD4747 | - | >98.00% | |
(9R, 12aR)-AZD4747 is a diastereomer of AZD4747. | ||||
| GC73540 | S07-1066 | 876625-29-5 | >99.00% | |
S07-1066 is an aldo-keto reductase 1C3 (AKR1C3) inhibitor, synergizing doxorubicin (DOX) cytotoxicity. | ||||
